Lodise, T., Yang, J., Puzniak, L. A., Dillon, R., & Kollef, M. (2020). Healthcare Resource Utilization of Ceftolozane/Tazobactam Versus Meropenem for Ventilated Nosocomial Pneumonia from the Randomized, Controlled, Double-Blind ASPECT-NP Trial. Infect Dis Ther.
Stile di citazione ChicagoLodise, Thomas, Joe Yang, Laura A. Puzniak, Ryan Dillon, e Marin Kollef. "Healthcare Resource Utilization of Ceftolozane/Tazobactam Versus Meropenem for Ventilated Nosocomial Pneumonia From the Randomized, Controlled, Double-Blind ASPECT-NP Trial." Infect Dis Ther 2020.
Citazione MLALodise, Thomas, et al. "Healthcare Resource Utilization of Ceftolozane/Tazobactam Versus Meropenem for Ventilated Nosocomial Pneumonia From the Randomized, Controlled, Double-Blind ASPECT-NP Trial." Infect Dis Ther 2020.